Are all successful renal transplants really successful?

Area of Science:

• Nephrology
• Transplant Surgery
• Immunology

Background:

• Some renal allografts show statistical success but lack clinical benefit.
• Graft survival between 6 months and 3 years represents a unique clinical challenge.

Purpose of the Study:

• To evaluate clinical outcomes in renal transplant recipients based on graft survival duration.
• To identify factors contributing to poor clinical benefit despite statistically successful allografts.

Main Methods:

• Retrospective analysis of 179 consecutive renal transplant recipients.
• Patients categorized into three groups based on graft survival: <6 months, 6 months–3 years, and >3 years.
• Comparison of demographic, clinical, and immunological factors across groups.

Main Results:

• No significant differences in age, cause of renal failure, HLA match, or immunosuppression.
• Patients with graft survival between 6 months and 3 years (Group 2) had significantly more acute rejections, hospitalizations, and complications compared to those with >3 years survival.
• Group 2 experienced 5x more rejections, 3x more hospitalizations, and 2x more complications than Group 3.

Conclusions:

• Renal transplant recipients with graft survival between 6 months and 3 years represent a vulnerable group with significant clinical burden.
• This cohort faces disproportionately high rates of rejection, hospitalization, and complications.
• Future research should focus on sensitive presensitization detection methods to improve graft outcomes.